Patent ID: 9026372
Filing Date: 2015-05-05
Classification: A61K,G16H,Y02A

Abstract:
1. A method of providing a system of care with a high-dose oxazaphosphorine drug regimen to treat or delay the onset of transplant rejection, comprising, carrying out the following steps prior to administration of the high-dose oxazaphosphorine drug regimen: a. registering a subject and generating a unique identifier for the subject in a non-transitory computerized storage medium; b. providing counseling to the subject regarding the risks associated with the administration of the high-dose oxazaphosphorine drug regimen, and obtaining the subject's informed consent for participation in the regimen; c. registering one or more of the following items in the storage medium: d. registering in the storage medium all pharmaceuticals or other substances currently being administered to the subject, and confirming in the storage medium that none of the pharmaceuticals include contraindicated pharmaceuticals or substances; e. computing an approval status code upon successful completion of steps a-d which corresponds to the subject's identifier within the storage medium; and f. transmitting to an administration facility authorization to administer the high-dose oxazaphosphorine drug regimen to the subject based on the approval status code, or transmitting to the drug manufacturer authorization to release the oxazaphosphorine of the high-dose oxazaphosphorine regimen to the administration facility based on the approval status code, causing the administration facility to administer the high-dose oxazaphosphorine drug regimen to the subject based on the approval status code, to treat or delay the onset of transplant rejection.